Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche's Xolair reduces reactions to severe food allergies in study
Reuters
Sun, 02/25/24 - 05:36 pm
Tags:
Roche, Novartis, Xolair, clinical trials, food allergies
What did Big Pharma CEOs get paid in 2023?
Medical Marketing and Media
Fri, 02/23/24 - 10:22 am
Tags:
Pharma CEOs, executive pay, AstraZeneca, Roche, Novartis
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel
Fierce Pharma
Thu, 02/22/24 - 11:40 am
Tags:
Rigel Pharmaceuticals, Gavreto, RET inhibitors, Blueprint Medicines, Roche
FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies
Fierce Pharma
Sun, 02/18/24 - 08:31 pm
Tags:
Roche, Novartis, Xolair, food allergies, FDA
Roche-Backed Freenome Continues Industry’s Funding Rally with $254M Raise
BioSpace
Thu, 02/15/24 - 11:16 am
Tags:
Freenome, multiomics, Roche, cancer, diagnostics, funding
Roche dumps Repare's synthetic lethal drug days after making $40M stitch in Tapistry trial
Fierce Biotech
Tue, 02/13/24 - 11:29 am
Tags:
Roche, Repare Therapeutics, solid tumors, clinical trials, synthetic lethality
Roche to shrink product development team, mainly impacting contractors
Fierce Biotech
Fri, 02/9/24 - 11:10 am
Tags:
Roche, drug development, layoffs, contractors
Roche gets first world okay for PNH drug crovalimab
Pharmaphorum
Thu, 02/8/24 - 10:58 am
Tags:
Roche, China, crovalimab, PNH
Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year
Fierce Pharma
Mon, 02/5/24 - 11:16 pm
Tags:
Novartis, Roche, Pharma CEOs, executive pay, Vas Narasimhan, Thomas Schinecker
Roche shares fall on modest 2024 outlook
Reuters
Thu, 02/1/24 - 11:16 am
Tags:
Roche, earnings
Roche reports data from Phase III retinal vein occlusion therapy trials
Clinical Trials Arena
Thu, 02/1/24 - 11:15 am
Tags:
Roche, Vabysmo, macular edema, central retinal vein occlusion
Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Tags:
Cour Pharmaceuticals, funding, autoimmune disease, Roche, Pfizer, Bristol Myers Squibb, nanoparticles
Hookipa, reeling from Roche’s KRAS cull, lays off 30% of workforce, deprioritizes programs
Fierce Biotech
Mon, 01/29/24 - 11:24 am
Tags:
Roche, Hookipa, layoffs, KRAS
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Fierce Biotech
Tue, 01/23/24 - 10:43 am
Tags:
Roche, Genentech, GenEdit, drug development, gene therapy, autoimmune disease
Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech
Fierce Biotech
Mon, 01/22/24 - 11:19 am
Tags:
Roche, Genentech, AC Immune, Alzheimer's diseasse
Roche racks up phase 3 TIGIT win, but trial design leaves doubts
Fierce Biotech
Wed, 01/17/24 - 09:33 am
Tags:
Roche, Tigit, immuno-oncology, tiragolumab, clinical trials
Roche is ‘on par’ with Novo, Lilly in GLP-1 race after $2.7B Carmot deal
Medical Devices and Diagnostics Industry
Fri, 01/12/24 - 11:33 am
Tags:
Roche, Carmot, GLP-1 agonist. obesity, Novo Nordisk, Eli Lilly
Roche Inks Potential $2B Deal with MOMA, Continues Early January Hot Streak
BioSpace
Fri, 01/5/24 - 09:47 am
Tags:
Roche, MOMA Therapeutics, KnowledgeBase
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
Tags:
clinical trials, Beam Therapeutics, Moderna Therapeutics, Pfizer, Sanofi, Gilead Sciences, JNJ, Amylx, Roche, Alnylam Pharmaceuticals, Vertex Pharmaceuticals
Get ready for the Roche (Remix), ft. a $30M small molecule deal
Fierce Biotech
Wed, 01/3/24 - 09:37 am
Tags:
Roche, Remix Therapeutics, small molecule drugs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.